Cargando…

Lentivirus‐mediated disintegrin and metalloproteinase 17 RNA interference reversed the acquired resistance to gefitinib in lung adenocarcinoma cells in vitro

Objective: The aim of the study is to evaluate the effects of silencing a disintegrin and metalloproteinase 17 (ADAM17) gene expression by lentivirus‐mediated RNA interference (RNAi) in the gefitinib‐resistant lung adenocarcinoma cells, and then to explore whether the recombinant lentivirus mediated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ya‐Qing, Liu, Yuan‐Shun, Ying, Xi‐Wang, Zhou, Hong‐Bin, Wang, Zhehua, Wu, Sheng‐Chang, Yan, Jian‐Ping, Jing, Yu‐Ting, Yang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585635/ https://www.ncbi.nlm.nih.gov/pubmed/28960861 http://dx.doi.org/10.1002/btpr.2564

Ejemplares similares

Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17
por: Yang, Guang, et al.
Publicado: (2021)

Diagnostic and prognostic value of a disintegrin and metalloproteinase-17 in patients with gliomas
por: WU, BIN, et al.
Publicado: (2014)

Lentivirus-mediated silencing of HOTAIR lncRNA restores gefitinib sensitivity by activating Bax/Caspase-3 and suppressing TGF-α/EGFR signaling in lung adenocarcinoma
por: Liu, Yuanshun, et al.
Publicado: (2018)

A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma
por: Kanzaki, Hiroyuki, et al.
Publicado: (2016)

Lentivirus-mediated silencing of CNTN1 enhances gefitinib sensitivity by reversing epithelial-mesenchymal transition in lung adenocarcinoma A549 cells
por: Hu, Chun-Sheng, et al.
Publicado: (2021)

Potential role of a disintegrin and metalloproteinase-17 (ADAM17) in age-associated ventricular remodeling of rats
por: Liu, Hainiang, et al.
Publicado: (2019)

The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas
por: Oh, S.-T., et al.
Publicado: (2016)

Expression of Migration-Related Genes in Human Colorectal Cancer and Activity of a Disintegrin and Metalloproteinase 17
por: Walkiewicz, Katarzyna, et al.
Publicado: (2016)

MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9)
por: Liu, Ruibao, et al.
Publicado: (2018)

The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family
por: Kelwick, Richard, et al.
Publicado: (2015)

Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases
por: Dreymueller, D., et al.
Publicado: (2017)

A Disintegrin and Metalloproteinase—Control Elements in Infectious Diseases
por: Aljohmani, Ahmad, et al.
Publicado: (2020)

Effect of aerobic exercise on acquired gefitinib resistance in lung adenocarcinoma
por: Yang, Hong, et al.
Publicado: (2021)

A Disintegrin and Metalloproteinase Domain 17 Regulates Colorectal Cancer Stem Cells and Chemosensitivity Via Notch1 Signaling
por: Wang, Rui, et al.
Publicado: (2016)

Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation
por: Shimoda, Masayuki, et al.
Publicado: (2016)

Inhibition of hepatocellular carcinoma cell proliferation, migration, and invasion by a disintegrin and metalloproteinase-17 inhibitor TNF484
por: Xia, Changhong, et al.
Publicado: (2019)

Deficiency of the Metalloproteinase-Disintegrin ADAM8 Is Associated with Thymic Hyper-Cellularity
por: Gossens, Klaus, et al.
Publicado: (2010)

Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
por: Matthews, Alexandra L., et al.
Publicado: (2017)

A disintegrin and metalloproteinase 17 mRNA and protein expression in esophageal squamous cell carcinoma, as well as its clinicopathological factors and prognosis
por: LIU, HONG-BIN, et al.
Publicado: (2015)

A metalloproteinase of the disintegrin and metalloproteinases and the ThromboSpondin Motifs 6 as a novel marker for colon cancer: functional experiments
por: Wang, Yun-Peng, et al.
Publicado: (2020)

Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12
por: Qi, Yue, et al.
Publicado: (2014)

Molecular characterization and expression of a disintegrin and metalloproteinase with thrombospondin motifs 8 in chicken
por: Lee, Ra Ham, et al.
Publicado: (2018)

Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis
por: Zhu, Ya-zhen, et al.
Publicado: (2021)

A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation
por: Yang, Xiaoyuan, et al.
Publicado: (2018)

Cholangiocarcinoma presenting with acquired thrombotic thrombocytopenic purpura confirmed by positive autoantibodies of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13
por: Li, Yue-Ting, et al.
Publicado: (2020)

Biological potentials for a family of disintegrin and metalloproteinase (ADAMDEC)-1 in mouse normal pregnancy
por: KUNIYOSHI, Nobue, et al.
Publicado: (2021)

A Disintegrin and Metalloproteinase (ADAM) Family—Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2022)

A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems
por: Xu, Jiaxi, et al.
Publicado: (2016)

Upregulation of a disintegrin and metalloproteinase-33 by VEGF in human airway smooth muscle cells: Implications for asthma
por: Pei, Qing-Mei, et al.
Publicado: (2016)

Acquired Gefitinib-Resistant Mutation of EGFR in a Chemonaive Lung Adenocarcinoma Harboring Gefitinib-Sensitive Mutation L858R
por: Gow, Chien-Hung, et al.
Publicado: (2005)

Relevance of A Disintegrin and Metalloproteinase Domain-Containing (ADAM)9 Protein Expression to Bladder Cancer Malignancy
por: Moriwaki, Michika, et al.
Publicado: (2022)

Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma
por: Honda, Hiroki, et al.
Publicado: (2017)

A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer
por: Chung, Hye Won, et al.
Publicado: (2019)

A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

A Disintegrin and Metalloproteinase Protein 8 (ADAM 8) in Autism Spectrum Disorder: Links to Neuroinflammation
por: Al-Ayadhi, Laila, et al.
Publicado: (2023)

Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib‐resistant lung adenocarcinoma cells
por: Ni, Jie, et al.
Publicado: (2018)

Downregulation of sperm-associated antigen 5 inhibits melanoma progression by regulating forkhead box protein M1/A disintegrin and metalloproteinase 17/NOTCH1 signaling
por: Dang, Lin, et al.
Publicado: (2022)

Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats
por: Permatasari, Dian Agustina, et al.
Publicado: (2019)

The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor
por: Atfi, Azeddine, et al.
Publicado: (2007)

A Disintegrin and Metalloproteinase10 (ADAM10) Regulates NOTCH Signaling during Early Retinal Development
por: Toonen, Joseph A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i93dcobgj72a1j1fn9n7ktu18c